VIM and hepatocellular carcinoma: Interestingly, in contrast to previous studies in gastric and colorectal cancers, where VIM-AS1 expression was increased and linked to increased cell migration, our study in HCC patients revealed decreased expression of VIM-AS1, which was associated with increased cell migration and invasion.